subsidiary and listed company, which was deemed dishonest act causing damage to GGC. They committed the offense with nine associates who were raw material distributors, namely (3) Anatta Green Co., Ltd
of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
Pattanamas, proceeded GGC to purchase raw materials and pay the distributors for the purchase in full without receiving all of the raw materials or receiving only part of it. However, GGC recorded in its
. Zait Pattanamas, proceeded GGC to purchase raw materials and pay the distributors for the purchase in full without receiving all of the raw materials or receiving only part of it. However, GGC recorded